Compare SNN to:
Real-Time: 49.72 -0.52 (-1.03%) 9:35am ET
| Last Trade: | 50.24 |
|---|---|
| Trade Time: | Feb 9 |
| Change: | 0.00 (0.00%) |
| Prev Close: | 50.24 |
| Open: | N/A |
| Bid: | N/A |
| Ask: | N/A |
| 1y Target Est: | 52.50 |
| Day's Range: | N/A - N/A |
|---|---|
| 52wk Range: | 30.01 - 53.66 |
| Volume: | 0 |
| Avg Vol (3m): | 86,725.4 |
| Market Cap: | 8.87B |
| P/E (ttm): | 19.32 |
| EPS (ttm): | 2.60 |
| Div & Yield: | 0.55 (1.10%) |
| Mon, Feb 8 | Smith & Nephew upgraded by UBSBriefing.com |
| Wed, Feb 3 | The International Negative Pressure Wound Therapy Expert Panel to Announce Results of Inaugural Symposium in HamburgPR Newswire |
| Wed, Feb 3 | International NPWT Expert Panel Convenes in HamburgPR Newswire |
| Mon, Feb 1 | Smith & Nephew Endoscopy Awarded Contract From Healthtrust Purchasing GroupPR Newswire |
| Mon, Jan 25 | 2010 Recovery In Capital Expenditures By Hospitals Will Benefit Specific Medical Equipment Sectors According To 14 Year Industry VeteranWall Street Transcript |
| Mon, Jan 25 | More British Stocks To Considerat Investopedia |
| Wed, Jan 20 | Smith & Nephew donates medical equipment to HaitiAP |
| Wed, Jan 20 | Smith & Nephew Orthopaedics Begins Distribution to Haiti of Trauma Implants and InstrumentsPR Newswire |
| Tue, Dec 22 | Smith & Nephew completes purchase of NucrystAP |
| Tue, Dec 22 | Smith & Nephew Completes Acquisition of the Assets of Nucryst Pharmaceuticals Corp.PR Newswire |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.